Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
This is why a Certificate of Analysis and third-party purity testing matter so much in the research market, and why nothing on this page should be read as health advice
Results for Phase II Clinical Trial of LCL161, a SMAC Mimetic, in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (post-PV MF) or Post-Essential Thrombocytosis Myelofibrosis (post-ET MF)
Not for human consumption, therapeutic use, or diagnostic procedures
BPC-157, short for Body Protection Compound-157, is a synthetic pentadecapeptide consisting of 15 amino acids, originally derived from a protective protein found in human gastric juice
Specific barriers that participants face may include (1) mistrust, (2) lack of comfort with the clinical trial process, (3) lack of information about clinical trials, (4) time and resource constraints associated with participation, and (5) lack of awareness about the existence and importance of clinical trials (Clark et al., 2019)
.jpg)